Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

L’Oreal to acquire 10% stake in Swiss skin care company Galderma

by Uma Rajagopal
0 comments
2024 08 05T054218Z 1 LYNXMPEK7405F RTROPTP 4 GALDERMA IPO

 

ZURICH (Reuters) -French cosmetics company L’Oreal is to acquire a 10% stake in Swiss skin care firm Galderma from a group of major shareholders, the two companies said on Monday.

The Swiss firm, originally set up as a joint venture between Nestle and L’Oreal, began trading on the Swiss stock exchange in late March, with its shares rising.

Galderma said L’Oreal would acquire the 10% stake for an undisclosed premium from Sunshine SwissCo AG – a consortium led by Swedish private equity firm EQT – Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd.

Galderma said it had signed a memorandum of understanding with L’Oreal to work towards a new research and development collaboration in the form of a scientific partnership focused on complementary research projects.

“It marks an ambitious step for L’Oreal, and true to our mantra of ‘seize what is starting,’ it allows us to explore partnering in the fast-growing aesthetics market, a key adjacency to our own pure beauty play,” said Nicolas Hieronimus, Chief Executive Officer of L’Oreal.

“We fully support Galderma’s management and its strategy as a leading dermatology pure player, respect its independence and are very confident in its long-term growth potential.”

L’Oreal said it will not seek to be represented at Galderma’s board of directors and has agreed to customary provisions for an investment of this type as part of a shareholders’ agreement with Sunshine SwissCo.

(Reporting by Dave Graham, Editing by Friederike Heine and Miranda Murray)